Alphatec Holdings (ATEC) Research & Development (2010 - 2026)
Alphatec Holdings (ATEC) reported Research & Development of $17.6 million for Q1 2026, up 5.9% on a YoY basis from $16.6 million in Q1 2025, and down 21.19% sequentially from $22.3 million in Q4 2025.
Alphatec Holdings (ATEC) Research & Development (2010 - 2026) Analysis & Trends
Alphatec Holdings (ATEC) has 17 years of Research & Development data on file, last reported at $17.6 million in Q1 2026.
- For the quarter ending Q1 2026, Research & Development rose 5.9% year-over-year to $17.6 million; the trailing twelve-month figure through Mar 2026 stood at $76.8 million (down 3.14% YoY), and the FY2025 full-year result was $76.3 million, down 5.51% from the prior year.
- Research & Development retreated to $17.6 million in Q1 2026, from $22.3 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $23.2 million in Q4 2024 to a low of $9.7 million in Q1 2022.
- A 5-year average of $17.0 million and a median of $18.0 million in 2024 frame the typical range for Research & Development.
- Across the five-year window, Research & Development jumped 92.04% in 2023 and retreated 8.24% in 2025, its largest moves.
- Tracing ATEC's Research & Development over 5 years: stood at $11.6 million in 2022, then jumped by 92.04% to $22.3 million in 2023, then gained by 4.31% to $23.2 million in 2024, then slipped by 4.14% to $22.3 million in 2025, then dropped by 21.19% to $17.6 million in 2026.
- Business Quant data shows ATEC's Research & Development at $17.6 million in Q1 2026, $22.3 million in Q4 2025, and $18.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Alphatec Holdings | 1.26 Bn | 1.12 Bn | 136.48 Mn | 17.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.56 Mn |
| Dec 31, 2025 | 22.28 Mn |
| Sep 30, 2025 | 18.68 Mn |
| Jun 30, 2025 | 18.28 Mn |
| Mar 31, 2025 | 16.58 Mn |
| Dec 31, 2024 | 23.24 Mn |
| Sep 30, 2024 | 20.36 Mn |
| Jun 30, 2024 | 19.11 Mn |
| Mar 31, 2024 | 18.01 Mn |
| Dec 31, 2023 | 22.28 Mn |
| Sep 30, 2023 | 20.00 Mn |
| Jun 30, 2023 | 14.57 Mn |
| Mar 31, 2023 | 13.26 Mn |
| Dec 31, 2022 | 11.60 Mn |
| Sep 30, 2022 | 12.11 Mn |
| Jun 30, 2022 | 10.60 Mn |
| Mar 31, 2022 | 9.72 Mn |
| Dec 31, 2021 | 8.98 Mn |
| Sep 30, 2021 | 9.39 Mn |
| Jun 30, 2021 | 7.84 Mn |